These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 7820079)
1. [Stable suppression of transcription of human papillomavirus type 18 (HPV 18) E6 and E7 genes in transformed rat fibroblasts: use of an antisense oligonucleotide to the E7 gene]. Komissarova EV; Pantin VI; Pavlova LS; Borovkova TV; Soĭfer MV; Shtutman MS; Zarytova VF; Ivanova EM; Sats NV; Grineva NI Dokl Akad Nauk; 1994 Sep; 338(3):404-7. PubMed ID: 7820079 [No Abstract] [Full Text] [Related]
2. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252 [TBL] [Abstract][Full Text] [Related]
3. Biologic activity of oligonucleotides with polarity and anomeric center reversal. Tan TM; Kalisch BW; van de Sande JH; Ting RC; Tan YH Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):95-101. PubMed ID: 9593047 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of translation of the bicistronic mRNA encoding human papillomavirus type 16 E6-E7 genes. Tan TM; Gloss B; Bernard HU; Ting RC J Gen Virol; 1994 Oct; 75 ( Pt 10)():2663-70. PubMed ID: 7931152 [TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer. Peto M; Tolle-Ersü I; Kreysch HG; Klock G J Gen Virol; 1995 Aug; 76 ( Pt 8)():1945-58. PubMed ID: 7636475 [TBL] [Abstract][Full Text] [Related]
6. Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV 16 E7 mRNA in CaSki cells. Lappalainen K; Urtti A; Jääskeläinen I; Syrjänen K; Syrjänen S Antiviral Res; 1994 Feb; 23(2):119-30. PubMed ID: 8147581 [TBL] [Abstract][Full Text] [Related]
7. Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines. Steele C; Cowsert LM; Shillitoe EJ Cancer Res; 1993 May; 53(10 Suppl):2330-7. PubMed ID: 7683572 [TBL] [Abstract][Full Text] [Related]
8. Kinetic selection of HPV 16 E6/E7-directed antisense nucleic acids: anti-proliferative effects on HPV 16-transformed cells. Venturini F; Braspenning J; Homann M; Gissmann L; Sczakiel G Nucleic Acids Res; 1999 Apr; 27(7):1585-92. PubMed ID: 10075988 [TBL] [Abstract][Full Text] [Related]
9. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes. Tan TM; Ting RC Cancer Res; 1995 Oct; 55(20):4599-605. PubMed ID: 7553636 [TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells. Hamada K; Sakaue M; Alemany R; Zhang WW; Horio Y; Roth JA; Mitchell MF Gynecol Oncol; 1996 Nov; 63(2):219-27. PubMed ID: 8910631 [TBL] [Abstract][Full Text] [Related]
12. Immortalization of normal human embryonic fibroblasts by introduction of either the human papillomavirus type 16 E6 or E7 gene alone. Yamamoto A; Kumakura S; Uchida M; Barrett JC; Tsutsui T Int J Cancer; 2003 Sep; 106(3):301-9. PubMed ID: 12845665 [TBL] [Abstract][Full Text] [Related]
13. Growth inhibition of cervical tumor cells by antisense oligodeoxynucleotides directed to the human papillomavirus type 16 E6 gene. Alvarez-Salas LM; Arpawong TE; DiPaolo JA Antisense Nucleic Acid Drug Dev; 1999 Oct; 9(5):441-50. PubMed ID: 10555151 [TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells. Al Moustafa AE; Foulkes WD; Wong A; Jallal H; Batist G; Yu Q; Herlyn M; Sicinski P; Alaoui-Jamali MA Oncogene; 2004 Jul; 23(30):5252-6. PubMed ID: 15229656 [TBL] [Abstract][Full Text] [Related]
15. Anti-sense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16. Storey A; Oates D; Banks L; Crawford L; Crook T Nucleic Acids Res; 1991 Aug; 19(15):4109-14. PubMed ID: 1651476 [TBL] [Abstract][Full Text] [Related]
16. Cervical/vaginal dysplasias of transgenic mice harbouring human papillomavirus type 16 E6-E7 genes. Sasagawa T; Kondoh G; Inoue M; Yutsudo M; Hakura A J Gen Virol; 1994 Nov; 75 ( Pt 11)():3057-65. PubMed ID: 7964615 [TBL] [Abstract][Full Text] [Related]
17. Effects of human papillomavirus type-specific antisense oligonucleotides on cervical cancer cells containing papillomavirus type 16. Wong YF; Chung TK; Cheung TH; Lam SK; Chang AM Med Oncol; 1994; 11(3-4):149-51. PubMed ID: 7633836 [No Abstract] [Full Text] [Related]
18. Antisense oligodeoxynucleotides to c-jun inhibits proliferation of transformed NIH 3T3 cells induced by E5a of HPV-11. Chen SL; Tsao LT; Tsao YP Cancer Lett; 1994 Sep; 85(1):119-23. PubMed ID: 7923094 [TBL] [Abstract][Full Text] [Related]
19. Transfer of the E6 and E7 genes of human papillomavirus type 18 into human epithelial cells via recombinant retrovirus infection. Wu CJ; Chang KS; Chang YS Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Aug; 30(3):123-34. PubMed ID: 10592818 [TBL] [Abstract][Full Text] [Related]
20. The expression levels of the human papillomavirus type 16 E7 correlate with its transforming potential. Liu Z; Ghai J; Ostrow RS; Faras AJ Virology; 1995 Feb; 207(1):260-70. PubMed ID: 7871737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]